Johnson & Johnson Stock price

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
156.8 USD -0.90% Intraday chart for Johnson & Johnson -2.77% +0.01%
Sales 2024 * 88.28B Sales 2025 * 90.69B Capitalization 378B
Net income 2024 * 20.94B Net income 2025 * 22.33B EV / Sales 2024 * 4.12 x
Net cash position 2024 * 14.08B Net cash position 2025 * 27.24B EV / Sales 2025 * 3.87 x
P/E ratio 2024 *
17.6 x
P/E ratio 2025 *
16.6 x
Employees 131,900
Yield 2024 *
3.14%
Yield 2025 *
3.29%
Free-Float 77.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.90%
1 week-2.77%
Current month-2.86%
1 month+0.13%
3 months+0.85%
6 months-3.51%
Current year+0.01%
More quotes
1 week
156.50
Extreme 156.5
162.68
1 month
156.44
Extreme 156.44
163.11
Current year
154.84
Extreme 154.84
163.58
1 year
144.95
Extreme 144.95
175.97
3 years
144.95
Extreme 144.95
186.69
5 years
109.16
Extreme 109.16
186.69
10 years
81.79
Extreme 81.79
186.69
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 88-12-31
Director of Finance/CFO 57 97-12-31
Chief Tech/Sci/R&D Officer 58 19-11-04
Members of the board TitleAgeSince
Director/Board Member 70 19-04-24
Director/Board Member 72 14-06-18
Director/Board Member 70 09-10-21
More insiders
Date Price Change Volume
24-03-18 156.8 -0.90% 6,602,255
24-03-15 158.2 -0.65% 13,165,500
24-03-14 159.2 -1.17% 6,988,264
24-03-13 161.1 -1.01% 6,260,000
24-03-12 162.7 +0.94% 8,018,736

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
156.8 USD
Average target price
174.4 USD
Spread / Average Target
+11.26%
Consensus
  1. Stock
  2. Equities
  3. Stock Johnson & Johnson - Nyse